Evolent Health, Inc. Quarterly Revenues in USD from Q1 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Evolent Health, Inc. quarterly/annual Revenues history and growth rate from Q1 2017 to Q4 2023.
  • Evolent Health, Inc. Revenues for the quarter ending December 31, 2023 was $556M, a 45.4% increase year-over-year.
  • Evolent Health, Inc. Revenues for the twelve months ending December 31, 2023 was $1.96B, a 45.3% increase year-over-year.
  • Evolent Health, Inc. annual Revenues for 2021 was $908M, a 1.8% decline from 2020.
  • Evolent Health, Inc. annual Revenues for 2020 was $925M, a 34.6% increase from 2019.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $1.96B $556M +$174M +45.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $1.79B $511M +$158M +44.9% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-23
Q2 2023 $1.63B $469M +$149M +46.6% Apr 1, 2023 Jun 30, 2023 10-K 2024-02-23
Q1 2023 $1.48B $428M +$131M +44% Jan 1, 2023 Mar 31, 2023 10-K 2024-02-23
Q4 2022 $1.35B $382M +$134M +54% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $1.22B $353M +$130M +58.5% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-23
Q2 2022 $1.09B $320M +$97.9M +44.1% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-23
Q1 2022 $990M $297M +$82M +38.1% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-23
Q4 2021 $908M $248M +$1.82M +0.74% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-24
Q3 2021 $906M $222M -$17.1M -7.14% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-24
Q2 2021 $923M $222M +$4.76M +2.19% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-24
Q1 2021 $918M $215M -$6.16M -2.79% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-24
Q4 2020 $925M $247M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $240M Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 $217M Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 $221M Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q1 2018 $140M +$33.5M +31.5% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-10
Q1 2017 $106M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.